[The REACH registry: baseline and 1-year results].
REACH is the largest international registry designed to identify the clinical characteristics of atherothrombosis in the real-life setting. The present study describes the baseline and 1-year follow-up characteristics of 67,888 patients with coronary, cerebrovascular or peripheral vascular disease (VD group) or with three or more risk factors for developing atherothrombosis (RFO group) followed-up by 5,473 physicians. At baseline the patients had a high prevalence of risk factors, especially obesity, insufficient treatment (69.4% statins and 78.6% platelet antiaggregants) and involvement of more than one vascular territory in 15.9%. At 1 year of follow-up, 4.24% had a combination of cardiovascular death, myocardial infarction or stroke (4.69% in the VD group and 2.15% in the ORF group). This finding was related to the number of diseased vascular territories (2.15% in the ORF group and 9.21% in patients with three diseased territories). The REACH registry shows that the patients studied had multiple vascular involvement, undertreatment and high morbidity.